Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Clinical trial NCT01721018 · COMPLETED
Trial details
- NCT number
- NCT01721018
- Sponsor
- Virttu Biologics Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-11-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.